The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial).
 
Masanori Tokunaga
Honoraria - Kaken Pharmaceutical; Taiho Pharmaceutical
 
Junki Mizusawa
No Relationships to Disclose
 
Nozomu Machida
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Daiichi Sankyo (Inst); Lilly (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Takeo Fukagawa
No Relationships to Disclose
 
Hitoshi Katai
No Relationships to Disclose
 
Yasunori Nishida
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Seiji Ito
Honoraria - Chugai Pharma; Lilly Japan; Olympus; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)
 
Takeshi Sano
Honoraria - Chugai Pharma; Covidien; Eisai; Ethicon; Lilly; Taiho Pharmaceutical; Yakult Honsha
 
Mitsuru Sasako
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Narikazu Boku
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Ajinomoto; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; Medtronic; Nihonkayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Research Funding - Chugai Pharma; Novartis; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Hiroshi Katayama
No Relationships to Disclose
 
Haruhiko Fukuda
Speakers' Bureau - Chugai Pharma; Taiho Pharmaceutical
 
Masanori Terashima
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Otsuka (Inst); Yakult Honsha (Inst)